February 4, 2025) - Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of Applied Therapeutics, Inc. (NASDAQ: APLT) securities between January 3, 2024 and December 2, 2024, both ...

Fate Therapeutics uses iPSC and gene editing to offer scalable off-the-shelf therapies. Read more to see why I rate FATE ...

A look at the shareholders of Checkpoint Therapeutics, Inc. ( NASDAQ:CKPT) can tell us which group is most powerful. With 56% stake, individual investors possess the maximum shares in the company. In ...

The United States market has shown resilience, remaining flat over the last week while achieving a notable 24% increase over the past year, with earnings projected to grow by 15% annually. In this ...

Valerio Therapeutics S.A. (Euronext Growth Paris: ALVIO) today announced a strategic decision to discontinue all clinical trials and associated activities, including the ongoing VIO-01 trial. This ...

Viking Therapeutics is a clinical-stage biotech company focused on developing weight-loss therapies. Read why I rate VKTX ...

CONTACT KESSLER TOPAZ MELTZER & CHECK, LLP: If you suffered Applied Therapeutics losses ... severe risk that the trial data would be rejected by the FDA in the context of a New Drug Application.

Celldex Therapeutics , Inc. (NASDAQ:CLDX), a biopharmaceutical company focused on developing innovative therapies for ...

CARGO Therapeutics, Inc. Investigated for Securities Fraud Violations - Contact the DJS Law Group to Discuss Your Rights - CRGX ...

A breakthrough CAR-T cell therapy, Qartemi, has been approved for blood cancer patients in India, offering new hope to those ...

Recent developments, however, suggest that strategies to treat pain are starting to match its complexity with a new ...

Jan. 29, 2025 (GLOBE NEWSWIRE) -- CARGO Therapeutics, Inc. (Nasdaq ... of a competitive benefit-risk profile for patients in the context of available treatment options. Therefore, we believe ...